Enhancer ID: | E_01_0654 |
Species: | mouse |
Position : | chr9:21138792-21140792 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Hemorrhagic brain injury |
Pubmed ID: | 30365933 |
Enhancer experiment: | LDH release assay, Luciferase assay,Quantitative real-time RT-PCR,Western blot, Immunohistochemical staining, |
Enhancer experiment description: | Thus, the , -unsaturated carbonyl is necessary for the interaction of compounds, such as shogaol, with Keap1, and these findings may be useful for screening novel ICH therapeutic agents that increase HO-1 expression. |
Target gene : | Keap1 |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Thus, the , -unsaturated carbonyl is necessary for the interaction of compounds, such as shogaol, with Keap1, and these findings may be useful for screening novel ICH therapeutic agents that increase HO-1 expression. |
TF name : | -- |
TF experiment: | LDH release assay, Luciferase assay,Quantitative real-time RT-PCR,Western blot, Immunohistochemical staining, |
TF experiment description: | Thus, the , -unsaturated carbonyl is necessary for the interaction of compounds, such as shogaol, with Keap1, and these findings may be useful for screening novel ICH therapeutic agents that increase HO-1 expression. |
Enhancer function : | Thus, the , -unsaturated carbonyl is necessary for the interaction of compounds, such as shogaol, with Keap1, and these findings may be useful for screening novel ICH therapeutic agents that increase HO-1 expression. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Thus, the , -unsaturated carbonyl is necessary for the interaction of compounds, such as shogaol, with Keap1, and these findings may be useful for screening novel ICH therapeutic agents that increase HO-1 expression. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|